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Abstract
Purpose Reduced-exertion high-intensity interval training (REHIT) is a genuinely time-efficient exercise intervention that 
improves aerobic capacity and blood pressure in men with type 2 diabetes. However, the acute effects of REHIT on 24-h 
glycaemia have not been examined.
Methods 11 men with type 2 diabetes (mean ± SD: age, 52 ± 6 years; BMI, 29.7 ± 3.1 kg/m2;  HbA1c, 7.0 ± 0.8%) participated 
in a randomised, four-trial crossover study, with continual interstitial glucose measurements captured during a 24-h dietary-
standardised period following either (1) no exercise (CON); (2) 30 min of continuous exercise (MICT); (3) 10 × 1 min at ~ 90 
 HRmax (HIIT; time commitment, ~ 25 min); and (4) 2 × 20 s ‘all-out’ sprints (REHIT; time commitment, 10 min).
Results Compared to CON, mean 24-h glucose was lower following REHIT (mean ± 95%CI: − 0.58 ± 0.41 mmol/L, p = 0.008, 
d = 0.55) and tended to be lower with MICT (− 0.37 ± 0.41 mmol/L, p = 0.08, d = 0.35), but was not significantly altered 
following HIIT (− 0.37 ± 0.59 mmol/L, p = 0.31, d = 0.35). This seemed to be largely driven by a lower glycaemic response 
(area under the curve) to dinner following both REHIT and MICT (− 11%, p < 0.05 and d > 0.9 for both) but not HIIT (− 4%, 
p = 0.22, d = 0.38). Time in hyperglycaemia appeared to be reduced with all three exercise conditions compared with CON 
(REHIT: − 112 ± 63 min, p = 0.002, d = 0.50; MICT: -115 ± 127 min, p = 0.08, d = 0.50; HIIT − 125 ± 122 min, p = 0.04, 
d = 0.54), whilst indices of glycaemic variability were not significantly altered.
Conclusion REHIT may offer a genuinely time-efficient exercise option for improving 24-h glycaemia in men with type 2 
diabetes and warrants further study.
Keywords Exercise · High-intensity interval training · Postprandial glucose · Continuous glucose monitoring · Type 2 
diabetes
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SIT  Sprint interval training
VO2  Oxygen uptake
VO2peak  Peak oxygen uptake
Wmax  Peak power output
Introduction
Exaggerated postprandial glycaemic excursions are strongly 
correlated with type 2 diabetes-related complications, 
including cardiovascular disease, which is a major cause of 
morbidity and mortality (Monnier and Colette 2015). How-
ever, studies employing continuous glucose monitoring 
(CGM) have shown that, despite pharmacological interven-
tion, a large proportion of patients with type 2 diabetes (and 
even those well controlled according to  HbA1c) still spend 
significant portions of the day in hyperglycaemia (van Dijk 
et al. 2011). This emphasises the importance of a multi-com-
ponent treatment approach in type 2 diabetes, incorporating 
regular exercise, which is an effective strategy for lowering 
postprandial glucose excursions (Van Dijk et al. 2013) and 
 HbA1c (Church et al. 2010) over and above improvements 
seen with first-line drug therapies. Whilst exercise training-
induced adaptations may result in an additive and more pro-
longed improvement in insulin sensitivity (i.e. > 72 h post-
training) (Dela et al. 1995), it is generally accepted that the 
cumulative impact of regular (i.e. daily) acute exercise on 
glycaemic control (van Dijk et al. 2012) is of greater clini-
cal importance for the long-term management of glycaemic 
control in type 2 diabetes (Colberg et al. 2016).
The exercise recommendations for individuals with type 2 
diabetes are similar as for the general population, suggesting 
a minimum of 150 min of moderate–vigorous-intensity aero-
bic exercise each week (Colberg et al. 2016; Garber et al. 
2011). However, self-report data suggest that adherence to 
these guidelines is poor in the general population (Allender 
et al. 2008; Hallal et al. 2012) and potentially even lower in 
those with type 2 diabetes (Morrato et al. 2007). The reasons 
for poor exercise adherence are numerous and complex, but 
a perceived lack of time is consistently reported as one of 
the important barriers in people with type 2 diabetes (Korki-
akangas et al. 2009). In response to this, submaximal high-
intensity interval training (HIIT) and supramaximal sprint 
interval training (SIT) have been proposed as time-efficient 
alternative exercise options for improving glycaemic con-
trol. Acute studies in overweight individuals (Little et al. 
2014) and people with type 2 diabetes (Terada et al. 2016) 
have shown superior improvements in glycaemic control 
with HIIT compared with 30–60 min of traditional MICT. 
Despite the case for a superior clinical benefit, the total time 
commitment, including recovery intervals, means that most 
HIIT protocols are not as time-efficient as often claimed. 
To date, the protocols studied generally require 20–60 min 
(Terada et al. 2016; Little et al. 2011; Gillen et al. 2012), 
which is no different (and in some cases, exceeds) than cur-
rent exercise recommendations for MICT (Colberg et al. 
2016; Garber et al. 2011). Moreover, there is currently vig-
orous debate about whether either HIIT or SIT would be 
appropriate exercise strategies for recommendation to the 
general population or specific patient populations, based 
on the hypothesised potential for ‘unpleasant’ perceptual 
responses (e.g. high perceived exertion and negative affect) 
to lead to low exercise adherence (Hardcastle et al. 2014). 
The total time commitment and potential for unpleasant per-
ceptual responses increase as a function of the number and 
duration of high-intensity efforts (Townsend et al. 2017). 
Thus, it is important to examine whether HIIT/SIT proto-
cols, with fewer and shorter high-intensity efforts, remain 
efficacious for improving insulin sensitivity and glycaemic 
control in type 2 diabetes (Vollaard and Metcalfe 2017).
There is evidence that HIIT/SIT protocols with fewer and/
or shorter sprints can improve glucose tolerance in healthy 
sedentary individuals (Metcalfe et al. 2012, 2016; Gillen 
et al. 2016). For example, we previously demonstrated that 
a modified SIT intervention, consisting of 10 min of low-
intensity cycling interspersed with two 20 s ‘all-out’ sprints 
[termed ‘reduced-exertion high-intensity interval training’ 
(REHIT)], was effective at improving insulin sensitivity in 
sedentary men over 6 weeks (Metcalfe et al. 2012). Impor-
tantly, these benefits were observed despite the low time 
commitment (10 min per session) and acceptable session 
ratings of perceived exertion (‘somewhat hard’). Ruffino 
et al. (2017) recently applied REHIT in type 2 diabetes and 
observed superior improvements in aerobic capacity and 
similar changes in resting blood pressure compared with 
a moderate-intensity walking intervention over an 8-week 
training period. REHIT did not improve insulin sensitivity or 
reduce 24-h mean glucose in this study, however, responses 
were captured 3  days following training cessation and 
improvements may have been lost at this time point (Ruf-
fino et al. 2017). Nevertheless, 8 weeks of REHIT did lower 
plasma frucotosamine concentrations (a marker of average 
blood glucose levels in the preceding 2–4-week period), 
suggesting improved glycaemic control during the training 
intervention (Ruffino et al. 2017). Yet, the acute effects of 
REHIT on post-exercise glycaemic control in people with 
type 2 diabetes have not been explored. Thus, the primary 
aim of this study was to examine the effect of a single bout 
of REHIT on 24-h glycaemia in men with type 2 diabe-
tes relative to a no-exercise control trial using continuous 
glucose monitors. Our primary hypothesis was that REHIT 
would improve glycaemic control relative to no exercise. 
We also studied the effects of a single bout of MICT and a 
single bout of HIIT compared with no exercise, as both have 
previously been shown to improve glycaemic control (Gillen 
et al. 2012; van Dijk et al. 2012).
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Methods
Ethical approval
This randomised-controlled acute crossover trial was con-
ducted at Ulster University, Northern Ireland (UK), between 
October 2016 and August 2017 (ClinicalTrials.gov regis-
tration: NCT03082859). The experimental protocol was 
approved by the Office for Research Ethics in Northern Ire-
land (RECA ref: 16/NI/0115) and conducted in accordance 
with the Declaration of Helsinki.
Participants
11 (n = 11) men, diagnosed with type 2 diabetes mellitus by 
a clinician 4 ± 3 (range 0.5–8) years previously, completed 
the full experimental procedures (Fig. 1; Table 1). Exclusion 
criteria included exogenous insulin therapy, currently taking 
more than two glucose-lowering medications, BMI ≥ 40 kg/
m2, classification as highly active on the international physi-
cal activity questionnaire (IPAQ) (Craig et al. 2003), and any 
contraindications to exercise, including any history of cardi-
ovascular or cerebrovascular disease, impaired renal or liver 
function, and hypertension not well controlled by standard 
medication. All participants were informed about the study, 
both verbally and in writing, before providing their writ-
ten consent to participate. Eligible participants completed 
a 12-lead exercise stress test on a cycle ergometer (Lode 
Corival; Lode, Groningen, Netherlands) and received clear-
ance for vigorous-intensity exercise from a clinical cardiac 
physiologist. At baseline, all medication was recorded and 
participants were instructed to maintain their usual dose/
timing/type of medication throughout the study period.
Pre‑experimental procedures
Following health screening, participants completed a maxi-
mal incremental cycling test to volitional exhaustion to 
determine peak oxygen uptake (V̇O2peak), peak power out-
put (Wmax) and peak heart rate  (HRmax). Following a 5-min 
n=62 enquiries received from 
potential participants
n=16 attended for screening visit 
and 12-lead ECG exercise test
46 not eligible or declined to participate 
following phone/email screening
n=21 not interested or lost contact
n=4 female
n=1 type 1 diabetes
n=3 too many medications
n=2 no time
n=4 too far to travel
n=2 too active
n=2 no T2D
n=3 aged >60 years
n=1 kidney disease
n=1 epilepsy
n=2 BMI too high n=11 enrolled onto study
n=5 not eligible to participate
1 high resting BP
1 high exercise BP
1 history of thyroid problems
2 clinically meaningful ECG abnormality
n=11 completed full experimental 
procedures
n=0 participants withdrew from study post 
enrolment
Fig. 1  Flow of participants through the study
Table 1  Participant characteristics (n = 11)
T2D type 2 diabetes
Characteristics Mean ± SD (range)
Age (years) 52 ± 6 (40–60)
Body mass (kg) 91.8 ± 10.4 (65.6-100.9)
Height (m) 1.76 ± 0.07 (1.66–1.89)
BMI (kg/m2) 29.7 ± 3.1 (23.8–34.1)
V̇O2max (ml/kg/min) 28.9 ± 4.8 (18.3–35.3)
Systolic blood pressure (mmHg) 125 ± 12 (114–148)
Diastolic blood pressure (mmHg) 78 ± 7 (70–88)
Mean arterial pressure 93 ± 8 (83–108)
Duration of T2D (years) 4 ± 3 (0.5-8)
Fasting glucose (mmol/l) 8.1 ± 1.2 (7.1–9.7)
HbA1c (mmol/mol) 52 ± 9 (38–67)
HbA1c (%) 7.0 ± 0.8 (5.6–8.3)
Medication (n)
 Metformin 7
 Metformin + sulfonylurea 4
 Blood pressure lowering 1
 Statin 5
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warm up at 50 W, the intensity was increased by 15 W/min 
until cadence could not be maintained at ≥ 50 rpm (Lode 
Corival). V ̇O2peak was determined as the highest ten-breath 
rolling average, V ̇O2 measured using an online gas analysis 
system (Cosmed Quark; CPET, Rome, Italy), and accepted if 
two or more of the following criteria were met: (1) volitional 
exhaustion, (2) a plateau in VȮ2 despite increasing intensity, 
(3) RER > 1.15, and (4) maximal heart rate within 10 beats 
of the age-predicted maximum (i.e. 220—age) (Howley et al. 
1995). This was the case for all participants. Participants 
also completed two familiarisation sessions, on separate 
days, each lasting approximately 20 min, to introduce par-
ticipants to the technique and effort required to perform all-
out cycling sprints.
Main experimental protocol
Each participant completed four main experimental trials 
(CON, REHIT, HIIT and MICT) in a randomised order 
(envelope method), with each trial taking place over 3 days. 
During each trial, participants underwent 24 h of continu-
ous glucose monitoring under standardised dietary intake 
and the following experimental conditions: (1) a no-exercise 
control condition (CON); (2) a single bout of high-intensity 
interval training (HIIT); (3) a single bout of reduced-exer-
tion high-intensity interval training (REHIT); and (4) mod-
erate–vigorous-intensity continuous exercise (MICT). Each 
trial was separated by at least 5 days, and prior to each trial, 
participants were asked to avoid any structured exercise for 
2 days. This was confirmed via physical activity monitoring 
using synchronised accelerometry and heart rate monitor-
ing with branched model equations (Actiheart, Cambridge 
Neurotechnology Ltd., Cambridge, UK). The Actiheart is 
a non-invasive physical activity monitor that is both reli-
able and valid, can accurately estimate energy expenditure 
across low-, moderate- and high-intensity physical activities, 
and provides useful quantitative data on patterns of physi-
cal activity, allowing a comprehensive characterisation of 
physical activity status (Thompson et al. 2006). Participants 
wore the monitor continuously (day and night) and were 
instructed to only remove it when showering or bathing. 
There were no differences in physical activity across the 
2 days prior to each experimental trial (p > 0.05 for all main 
effects of condition, respectively; Table 2). The Actiheart 
monitors were also worn throughout each main 24-h moni-
toring period.
Participants attended the lab between 15:00 and 18:00 h 
on day 1 for insertion of a subcutaneous glucose sensor 
(Enlite, Medtronic Inc., Minneapolis, USA) and CGM in the 
abdomen (iPro2, Medtronic Inc. Minneapolis, USA). Sen-
sors were inserted approximately 5 cm from the umbilicus 
and on the opposite side from which participants tended to 
sleep on. The iPro2 measures glucose in the interstitial fluid 
every 5 min and values are subsequently converted to blood 
glucose using capillary measurements taken by each partici-
pant before each main meal and before sleep (Accu-Check; 
Roche Diagnostics, Basel, Switzerland). It has previously 
shown good validity and reliability when compared to blood 
glucose measured simultaneously from an intravenous can-
nula (Bailey et al. 2014). Participants then returned home 
but were provided with a standardised evening meal and 
snack (Table 2).
Participants returned to the laboratory the following 
morning (day 2) between 07:00 and 08:30 h to consume 
breakfast and complete the exercise session (30 min post-
breakfast). During CON, participants remained sedentary 
throughout this entire period (i.e. ~ 2 h). Participants then 
returned to their normal daily routine but were provided 
with standardised meals (lunch, evening meal, snacks, to 
be consumed at standardised times (Table 2)). Participants 
returned to the laboratory the following morning for removal 
of the CGM.
Dietary standardisation
Participants were provided with a standardised food and 
(energy containing) drink packages containing meals, snacks 
and drinks for each 42 h trial period (~ 18:00 h on day 1 to 
~ 12:00 h on day 3; Table 3). The diet was designed to meet 
resting metabolic rate [determined using the Harris and Ben-
edict equation (Harris and Benedict 1918)] multiplied by a 
PA level of 1.4. The macronutrient content was composed 
according to the 2008 ADA dietary recommendations for 
type 2 diabetes (Bantle et al. 2008) and consisted of three 
meals and snacks per full day. The contents of the dietary 
package were self-selected by participants (in consultation 
Table 2  Dietary composition for the pre-trial evening meal and the 
main trial day
Data shown as mean ± SD
CHO carbohydrate, Pro protein
Pre-trial even-
ing meal (day 
1)
Main trial day (day 2)
Total energy content 796 ± 187 2441 ± 235
CHO (kcal) 365 ± 79 1243 ± 100
Fat (kcal) 261 ± 99 761 ± 156
Pro (kcal) 171 ± 49 436 ± 49
CHO (%) 47 ± 8 51 ± 3
Fat (%) 32 ± 7 31 ± 4
Pro (%) 21 ± 4 18 ± 2
Breakfast (% of total energy) – 20 ± 5
Lunch (% of total energy) – 29 ± 4
Dinner (% of total energy) – 30 ± 5
Snacks (% of total energy) – 21 ± 6
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with the principle investigator) from a pre-determined list 
of foods available from a local supermarket. In this way, 
individual food preferences and tolerances were taken into 
account but the investigators were able to ensure appropriate 
energy and macronutrient content (Bantle et al. 2008). The 
food and drinks were ingested at pre-determined times for 
each participant so that a completely standardised diet was 
consumed during all four experimental trials. In addition 
to any energy-containing drinks provided to participants in 
food packages, participants were allowed to consume water 
ad libitum throughout each trial.
Exercise bouts
REHIT
The REHIT bout was performed on a mechanically braked 
cycle ergometer (Monark Peak Bike; Monark, Vansbro, Swe-
den) and was based on the protocol used in previous studies 
(Metcalfe et al. 2012, 2015, 2016; Ruffino et al. 2017). It 
consisted of 10 min of unloaded pedalling interspersed with 
two ‘all-out’ sprints against a resistance equivalent to 5% of 
body mass. Just before each sprint, participants increased 
their pedal cadence to their maximal speed; the braking force 
was applied to the ergometer and participants maintained 
the highest possible cadence against the resistance for 20 s. 
Sprints were performed at 2 min 40 s and 6 min 40 s into the 
10-min exercise session.
HIIT
The HIIT bout was performed on an electronically braked 
cycle ergometer (Lode Corival; Lode, Groningen, Nether-
lands) and involved 10 × 60 s cycling efforts interspersed 
with 60 s of low-intensity recovery (25 W) as previously 
described (Little et al. 2011; Gillen et al. 2012). Individual 
workloads were set at 85% Wmax, as pilot work has suggested 
this was appropriate for achieving ~ 90% maximal heart rate 
 (HRmax) during the final intervals.
MICT
MICT was performed on an electronically braked cycle 
ergometer (Lode Corival; Lode, Groningen, Netherlands) 
and involved 30 min of continuous cycling at an intensity 
equivalent to 50% of Wmax with a 2-min warm up and cool 
down (25 W) as previously described (van Dijk et al. 2012).
Calculations
The 24-h period of interest for continuous glucose measure-
ments commenced at the start of the breakfast period on 
day 2. The continuous glucose data were exported to Excel 
(Microsoft, Washington, USA), the relevant 288, 5-min rep-
licate values were isolated, and subsequently converted in 
summary variables including mean 24-h glucose (primary 
outcome), and secondary outcomes including glycaemic var-
iability, proportion of time in hyperglycaemia, 24-h incre-
mental (above fasting; calculated from the mean glucose 30 
min prior to breakfast) AUC (iAUC), and the total AUC for 
3 h breakfast, lunch and dinner responses. AUC was cal-
culated using the trapezoid rule. The 3-h postprandial glu-
cose (3-h PPG) was defined as mean glucose 150–180 min 
following each main meal. The glycaemic range, the mean 
amplitude of glycaemic excursions (MAGE) and the con-
tinuous overall net glycaemic action (CONGA) were calcu-
lated as measures of glycaemic variability (Rodbard 2009) 
using a freely available Excel Macro (Easy GV 9.0; available 
at http://www.easyg v.co.uk). The hyperglycaemic threshold 
was defined as ≥ 9 mmol/l based on the published Interna-
tional Diabetes Federation criteria (International Diabetes 
Federation 2014).
For the analysis of the Actihearts, minute by minute 
energy expenditure was calculated using the manufacturers 
Table 3  Actiheart-derived physical activity energy expenditure prior to and during each experimental trial
Data shown are mean ± SD
TEE total energy expenditure, PAL physical activity level, PA physical activity
*p < 0.05 vs control
^p = 0.06 vs control
Pre-trial (2 days) Main trial day
CON REHIT HIIT MICT CON REHIT HIIT MICT
TEE (Kcal/day) 2869 ± 363 2847 ± 319 3000 ± 487 2889 ± 307 2719 ± 258 2913 ± 435 3325 ± 641* 3225 ± 356*
PAL 1.49 ± 0.18 1.48 ± 0.17 1.56 ± 0.24 1.51 ± 0.15 1.41 ± 0.12 1.51 ± 0.21 1.73 ± 0.32* 1.69 ± 0.16*
Sedentary time (mins) 1107 ± 119 1091 ± 139 1062 ± 155 1083 ± 132 1166 ± 91 1091 ± 120 1000 ± 146* 1006 ± 95*
Light PA (mins) 244 ± 84 271 ± 99 265 ± 108 263 ± 96 212 ± 62 257 ± 72* 282 ± 72* 294 ± 69*
Moderate PA (mins) 85 ± 55 77 ± 53 107 ± 77 93 ± 45 61 ± 43 87 ± 65 135 ± 96^ 119 ± 52^
Vigorous PA (mins) 4 ± 11 1 ± 1 6 ± 14 1 ± 2 1 ± 1 5 ± 7 21 ± 16* 21 ± 24
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software (Actiheart, Cambridge Neurotechnology Ltd., 
Cambridge, UK) and subsequently exported to Microsoft 
Excel for determination of physical activity summary vari-
ables including total 24-h energy expenditure (TEE), physi-
cal activity level (PAL; total energy expenditure / resting 
energy expenditure), sedentary time (mins < 1.5 METs), 
time in light PA (mins > 1.5 METs but < 3 METs), time in 
moderate PA (mins > 3 METs and < 6 METs) and time in 
vigorous PA (mins > 6 METs) (Haskell et al. 2007; Pate et al. 
2008).
Statistical analysis
All statistical analysis was performed in GraphPad Prism 7 
for Mac OS X. Differences between conditions for exercise 
responses (i.e. power output and exercise energy expendi-
ture), as well as for 24-h CGM and PA summary variables, 
were compared using a one factor (condition) repeated meas-
ures ANOVA. ANOVA was performed regardless of any 
minor deviances from a normal distribution and with the 
Greenhouse–Geisser correction applied in cases of violated 
sphericity (Maxwell and Delaney 2004). If significant main 
effects were observed for 24-h CGM and PA variables, then 
to address our planned primary aim and hypothesis we com-
pared each of the three exercise conditions to control with a 
paired t-test and a Bonferroni correction for multiple com-
parisons. For comparisons of exercise responses, the one-
way ANOVA was followed up with Bonferroni-corrected 
t tests to locate differences between exercise conditions. 
Statistical significance was set at p ≤ 0.05 (two-tailed) and, 
unless stated otherwise, data are presented as mean ± SD. 
Cohens d was calculated as a measure of effect size with the 
following thresholds: small (d = 0.2), medium (d = 0.6) and 
large (d = 1.2) effect.
Results
Exercise characteristics/intervention fidelity
All participants successfully completed the three exercise 
sessions. During the exercise work intervals, mean power 
output was lowest during MICT (97 ± 17 W), higher dur-
ing HIIT (165 ± 28  W, p < 0.05 vs MICT), and higher 
still following REHIT (417 ± 49 W, p < 0.05 vs HIIT and 
MICT). On the other hand, Actiheart-estimated energy 
expenditure during exercise was, on average, lowest dur-
ing REHIT (251 ± 94 kJ), higher during HIIT (921 ± 279 kJ, 
p < 0.05 vs REHIT), and tended to be highest during MICT 
(1076 ± 378  kJ, p < 0.05 vs REHIT, p = 0.07 vs HIIT). 
During REHIT, peak, average and end power output were 
5.9 ± 0.7, 4.8 ± 0.6 and 3.7 ± 0.6 W/kg for the first sprint, 
and 5.6 ± 0.5, 4.4 ± 0.5 and 3.2 ± 0.6 W/kg for the second 
sprint, respectively.
MICT elicited a mean exercise heart rate of 80 ± 5% of 
the  HRmax achieved during the VO2peak test, whilst during the 
HIIT work intervals there was a progressive increase in heart 
rate, which reached 89 ± 5%, 90 ± 5%, 91 ± 5%, 92 ± 4% 
and 94 ± 5% of  HRmax during intervals 6–10, respectively 
(Fig. 2). Heart rate during REHIT peaked at 86 ± 4% and 
91 ± 3% of  HRmax during sprint 1 and 2, respectively, but 
mean exercise heart rate during REHIT was 74 ± 12% of 
 HRmax (Fig. 2).
The impact of the four-trial conditions on 24-h physical 
activity energy expenditure derived from the Actihearts is 
shown in Table 2. There were significant main effects of 
condition for all PA parameters (p < 0.05 for all). Both HIIT 
and MICT appeared to increase total 24-h energy expendi-
ture (p < 0.05 for both), light PA (p < 0.05 for both), mod-
erate PA (p = 0.06 for both), and decrease sedentary time 
(p < 0.05 for both), when compared with CON. Vigorous PA 
was significantly increased with HIIT compared with CON 
only (p < 0.05). Although 24-h TEE, light PA, moderate PA, 
and vigorous PA were higher, and sedentary time lower, on 
average with REHIT compared with CON, the differences 
were smaller and [with the exception of light PA (p < 0.05)] 
not statistically significant.
Effects of exercise on glycaemic parameters
24-h summary variables
The mean effect of exercise on 24-h glycaemic summary 
variables is shown in Table 4 with individual participant 
change scores (exercise minus control) for key summary 
Fig. 2  Heart rate responses over time with each exercise session. Data 
are presented as mean and SEM for visual clarity
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variables shown in Fig. 3. There were significant effects of 
condition for mean 24-h glucose (p = 0.05), time in hypergly-
caemia (p = 0.04) and for 24-h iAUC (p = 0.02). Mean 24-h 
glucose was lower during REHIT (p = 0.008, d = 0.55) and 
tended to be lower during MICT (p = 0.08, d = 0.35) when 
compared to CON, but there was no statistically significant 
change observed with HIIT (p = 0.31, d = 0.35). Time spent 
in hyperglycaemia appeared to be lower following all three 
exercise conditions compared with CON (REHIT: p = 0.002, 
d = 0.50; MICT: p = 0.08, d = 0.50; HIT: p = 0.04, d = 0.54), 
whilst 24-h iAUC was significantly reduced following MICT 
only (p = 0.02, d = 0.89). There were no significant changes 
in 24-h SD, glycaemic range, MAGE or CONGA with any of 
the exercise conditions (p > 0.05 for all main effects, respec-
tively; Table 4).
Meal responses
The 3-h glycaemic responses to breakfast, lunch and dinner 
are shown in Fig. 4 with additional postprandial summary 
variables in Table 4. There were no differences between 
conditions in the glycaemic response to breakfast or lunch 
(both p > 0.05, respectively). However, there was a signifi-
cant effect of condition on the AUC for dinner (p = 0.004), 
with lower AUC following REHIT (− 11%, p = 0.018, 
d = 1.05) and MICT (− 11%, p = 0.006, d = 0.99) compared 
with CON. The glycaemic response to dinner was not sig-
nificantly affected by HIIT (−4%, p = 0.22, d = 0.38). There 
were no significant main effects of condition on any other 
postprandial variable (Table 4).
Adverse events
One participant reported subjective symptoms of hypogly-
caemia between lunch and dinner during the HIIT trial; how-
ever, glucose recorded via the CGM appeared to be within 
the normal range (between 5 and 6 mmol/l). There were no 
other adverse events.
Discussion
This study examined the acute effects of three discordant 
exercise strategies, performed after breakfast, on CGM-
derived 24-h glycaemic control in 11 men with type 2 diabe-
tes. We replicate the findings of numerous previous studies 
that have shown the beneficial effects of a single 30-min bout 
of MICT on the 24-h glycaemic profile in type 2 diabetes 
(van Dijk et al. 2012, 2013), and provide the first evidence 
to suggest that a modified SIT protocol (REHIT), requiring 
40 s of high-intensity exercise within a total time commit-
ment of 10 min, is also associated with positive glycaemic 
effects in the post-exercise period. This finding is both novel 
and of potential significance, as it provides the first evidence 
for a genuinely time-efficient exercise option to improve 
glycaemic control in individuals with type 2 diabetes who 
currently perceive lack of time as a barrier to performing 
regular structured exercise (Korkiakangas et al. 2009).
REHIT was associated with small (Cohens d between 0.2 
and 0.6) but significant beneficial decreases in 24-h mean 
glucose and the prevalence of hyperglycaemia relative to 
a no-exercise control trial. This appears to have been pre-
dominantly driven by a marked reduction in the glycaemic 
response to the evening meal, as the breakfast and lunch 
responses were not significantly affected. Importantly, the 
improvements in glycaemic control were observed in addi-
tion to the impact of participants’ current medication, given 
the response to the no exercise (i.e. medication only) control 
trial. It is well established that hyperglycaemia is associated 
with endothelial cell stress and subsequent vascular dysfunc-
tion (Paneni et al. 2013), whilst improving glycaemic control 
reduces the risk of microvascular complications in type 2 
diabetes (Stolar 2010). This is largely based on analysis of 
fasting glucose concentrations, OGTT glucose responses, 
or  HbA1c, as estimates of glycaemic control, so it is dif-
ficult to draw direct comparisons on relative risk reduction 
for microvascular complications based on CGM variables 
(Monnier and Colette 2015). For example, a reduction in 
Fig. 3  Effect of exercise on 24-h CGM summary variables. Data are presented as mean change (bars) with individual change scores (dots) com-
pared with CON
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mean 24-h glucose can reflect changes during both ‘ambi-
ent’ and ‘postprandial’ periods (Monnier and Colette 2015). 
Nevertheless, it is reasonable to suggest that the ~ 0.5 mmol/l 
average reduction in 24-h mean glucose and ~ 2-h reduc-
tion in the prevalence of postprandial hyperglycaemia (per 
day) observed with REHIT, when performed on a regular 
Fig. 4  Glucose time responses (a, c, e) and AUC (b, d, f) for break-
fast (a, b), lunch (c, d) and dinner (e, f). *Denotes p < 0.05 vs CON. 
Glucose time responses are presented as means only for clarity, whilst 
AUCs are presented as mean change (bars) with individual change 
scores (dots) compared with CON
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basis, would make a meaningful impact on overall glycaemia 
(i.e.  HbA1c) and hence long-term risk (Monnier and Colette 
2015). The lower glucose AUC (− 11%) observed following 
dinner further supports this assertion, given that the rela-
tive contribution of postprandial hyperglycaemia to overall 
glycaemic exposure is greater in patients with  HbA1c ≤ 7.3% 
(Monnier and Colette 2015).
There is also a strong correlation between postprandial 
hyperglycaemia and the risk of adverse cardiovascular 
events (Coutinho et al. 1999). However, whether intervening 
to improve glycaemic control lowers cardiovascular risk over 
the long term is currently contentious (Wing et al. 2013). 
Nonetheless, combined with evidence that REHIT improves 
cardiorespiratory fitness and resting blood pressure with 
8 weeks of thrice weekly training sessions (Ruffino et al. 
2017), the current study provides further (tentative) evidence 
that REHIT favourably modifies the cardiovascular risk pro-
file in those with type 2 diabetes. The lack of improvement 
in insulin sensitivity and glycaemic control reported 3 days 
after the final training session by Ruffino et al. (2017) sug-
gests that the positive acute effects on glycaemic control are 
short lived. Future research should determine the optimal 
frequency of REHIT to maintain the acute benefits on gly-
caemic control.
The fact we could largely replicate the findings of pre-
vious studies on MICT and glycaemic control (van Dijk 
et al. 2012, 2013) validates our methodology and strength-
ens these preliminary findings with REHIT. However, 
it should be highlighted that the magnitude of the effects 
observed with both MICT and REHIT in the present study 
are smaller than in previous studies (van Dijk et al. 2012, 
2013). We suspect that this is explained by the fact that our 
participants’ type 2 diabetes was relatively well controlled 
according to  HbA1c. Van Dijk et al. (2013) demonstrated 
that reductions in, for example, mean 24-h glucose were 
lower (− 0.6 mmol/l vs − 1.2 mmol/l) in well controlled 
 (HbA1c < 7.0%) compared with sub-optimally controlled 
 (HbA1c > 7%) individuals with type 2 diabetes, respectively. 
The mean reductions in 24-h glucose of ~ 0.6 mmol/l with 
REHIT and ~ 0.4 mmol/l with MICT in the present study are, 
therefore, in line with the literature (Van Dijk et al. 2013).
The lack of statistically significant improvement in most 
glycaemic parameters with HIIT is an unexpected finding, 
particularly given the improvements observed with REHIT. 
Gillen et al. (2012) used a comparable HIIT protocol, trial 
design, and participants (n = 7) of similar diabetic status, 
and reported that HIIT markedly lowered average post-
meal glucose spikes, as well as the glucose concentrations 
60–120 min after the three post-exercise meals. In contrast, 
we observed no significant change in the AUC to any post-
exercise meal or in any other marker of postprandial glycae-
mia. Similar, however, was the lower prevalence of hypergly-
caemia despite no significant change in mean 24-h glucose 
(Gillen et al. 2012). It is important to highlight that the mean 
change for several of the glycaemic variables assessed with 
HIIT were in a favourable direction in the current study, but 
there was greater variation in individual change scores than 
with REHIT and MICT. It is possible that with an increased 
sample size and greater statistical power we would have 
observed effects of HIIT on other glycaemic parameters. 
Considering the accumulating evidence for beneficial train-
ing effects with this HIIT protocol in type 2 diabetes (Little 
et al. 2011; Francois et al. 2017), we would encourage larger 
definitive studies of the acute effects on glycaemic control.
There are several considerations in the study design and 
employed techniques that should be acknowledged. First, 
although we provided standardised food packages during all 
trials, and asked participants to record the time of their med-
ication, the study was otherwise free-living and (although 
this is also a strength of the study) we only have participants’ 
self-reported compliance. In addition, although CGM cap-
tures glycaemic data outside the laboratory and has shown 
good agreement with responses measured simultaneously in 
venous blood (Bailey et al. 2014), the coefficient of variation 
for some parameters can be high (Terada et al. 2014). The 
fact we could detect differences despite this lower level of 
control is encouraging, but we acknowledge that our small 
sample size, although consistent with numerous other stud-
ies on this topic (van Dijk et al. 2012, 2013; Manders et al. 
2010), is a key limitation and our data should be interpreted 
with caution in that context. Larger free-living CGM studies 
combined with more controlled laboratory assessments will 
be required to confirm our preliminary findings. We were 
also only able to capture postprandial glucose responses in 
this study and can provide no mechanistic insight, and so 
future investigations should aim to provide a more holis-
tic and mechanistic assessment of carbohydrate and lipid 
metabolism following REHIT in both men and women with 
type 2 diabetes.
In conclusion, this study suggests that a brief bout of 
REHIT improves markers of postprandial glycaemic con-
trol over the following 24-h period when compared with no 
exercise. We conclude that REHIT may offer a genuinely 
time-efficient exercise option for men with type 2 diabetes 
and warrants further study.
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